Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Status:
Withdrawn
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the treatment of skin growths called actinic
keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other
conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil
(5-FU).